Inspire Medical Systems (INSP) Competitors

Inspire Medical Systems (NYSE:INSP) and Zimmer Biomet (NYSE:ZBH) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, community ranking, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends.

Does the media prefer INSP or ZBH?

In the previous week, Zimmer Biomet had 3 more articles in the media than Inspire Medical Systems. MarketBeat recorded 14 mentions for Zimmer Biomet and 11 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 0.78 beat Zimmer Biomet's score of 0.75 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspire Medical Systems	7 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zimmer Biomet	6 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility and risk, INSP or ZBH?

Inspire Medical Systems has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Comparatively, Zimmer Biomet has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500.

Does the MarketBeat Community prefer INSP or ZBH?

Zimmer Biomet received 713 more outperform votes than Inspire Medical Systems when rated by MarketBeat users. Likewise, 67.16% of users gave Zimmer Biomet an outperform vote while only 61.31% of users gave Inspire Medical Systems an outperform vote.

Company	Underperform	Outperform
Inspire Medical Systems	Outperform Votes 187 61.31%	Underperform Votes 118 38.69%
Zimmer Biomet	Outperform Votes 900 67.16%	Underperform Votes 440 32.84%

Is INSP or ZBH more profitable?

Zimmer Biomet has a net margin of 14.27% compared to Inspire Medical Systems' net margin of 4.37%. Zimmer Biomet's return on equity of 12.95% beat Inspire Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspire Medical Systems	4.37%	5.30%	4.58%
Zimmer Biomet	14.27%	12.95%	7.55%

Which has preferable valuation and earnings, INSP or ZBH?

Zimmer Biomet has higher revenue and earnings than Inspire Medical Systems. Zimmer Biomet is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspire Medical Systems	$624.80M	8.54	-$21.15M	$1.07	166.33
Zimmer Biomet	$7.60B	2.87	$1.02B	$5.26	20.85

Do institutionals & insiders hold more shares of INSP or ZBH?

94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 88.9% of Zimmer Biomet shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by insiders. Comparatively, 1.0% of Zimmer Biomet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Do analysts rate INSP or ZBH?

Inspire Medical Systems currently has a consensus target price of $232.55, suggesting a potential upside of 30.67%. Zimmer Biomet has a consensus target price of $123.33, suggesting a potential upside of 12.47%. Given Inspire Medical Systems' stronger consensus rating and higher probable upside, equities analysts clearly believe Inspire Medical Systems is more favorable than Zimmer Biomet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspire Medical Systems	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Zimmer Biomet	2 Sell rating(s)	11 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

Inspire Medical Systems and Zimmer Biomet tied by winning 9 of the 18 factors compared between the two stocks.